Medallion Metals Limited (ASX:MM8)
0.2250
-0.0150 (-6.25%)
Aug 1, 2025, 4:10 PM AEST
Inozyme Pharma Revenue
Medallion Metals had revenue of 744.59K AUD in the half year ending December 31, 2024, a decrease of -51.64%. This brings the company's revenue in the last twelve months to 1.48M, down -44.12% year-over-year. In the fiscal year ending June 30, 2024, Medallion Metals had annual revenue of 1.86M, down -39.29%.
Revenue (ttm)
1.48M
Revenue Growth
-44.12%
P/S Ratio
93.01
Revenue / Employee
n/a
Employees
n/a
Market Cap
137.47M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 1.86M | -1.20M | -39.29% |
Jun 30, 2023 | 3.06M | 871.91K | 39.84% |
Jun 30, 2022 | 2.19M | 1.57M | 254.70% |
Jun 30, 2021 | 616.93K | 113.03K | 22.43% |
Jun 30, 2020 | 503.90K | -1.46M | -74.29% |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BHP Group | 87.21B |
Fortescue | 26.41B |
Northern Star Resources | 5.54B |
Evolution Mining | 3.91B |
South32 | 10.04B |
BlueScope Steel | 16.43B |
Orica | 7.95B |
Lynas Rare Earths | 482.82M |